Please join Jasper Therapeutics for a webinar to present findings from its investigation into the anomalous results from the BEACON study in CSU reported in July, as well as preliminary data from the ETESIAN study in asthma. The webinar will include remarks from Jasper management as well as Dr. Martin Metz, M.D., Professor of Dermatology and Allergy, Charité – Universitätsmedizin Berlin, and lead EU investigator in the BEACON study. A live question and answer session will follow the formal presentation.